News Daily News Crushing It: Cangrelor and Ticagrelor Can Be Used Together Safely in STEMI, Small Study Hints Todd Neale January 14, 2019
News Conference News ESC 2017 ESC Updates Guidelines for Treating STEMI Patients Michael O'Riordan August 27, 2017
News Daily News With No RCTs, Propensity-Score Matched Analysis Informs Choice Between Cangrelor and GPIs in the Cath Lab Yael L. Maxwell December 06, 2016
News Daily News Sin ECA, el Análisis de Emparejamiento por Puntuación de la Propensión permite tomar una Decisión Informada entre Cangrelor y GPI en el Laboratorio de Cateterización Yael L. Maxwell December 06, 2016
Presentation ESC 2016 “Off Hours” Versus “On Hours” Presentation in ST-Segment Elevation Myocardial Infarction: Findings from CHAMPION PHOENIX Presenter: Deepak L. Bhatt August 31, 2016
News Conference News TCT 2015 Experts Debate Optimal Pharmacologic Approach for STEMI Patients October 11, 2015
News Daily News No Interplay Between Access Site, Cangrelor Effects in PCI Patients Caitlin E. Cox October 06, 2015
News Daily News No hay interacción entre el punto de acceso y los efectos del Cangrelor en pacientes con PCI Caitlin E. Cox October 06, 2015
Presentation CHAMPION PHOENIX: Effect of Cangrelor and Access Site on Ischemic and Bleeding Events Presenter: JA. Gutierrez October 05, 2015
News Industry News The Medicines Company Authorizes Generic Launch of ANGIOMAX® (bivalirudin) July 09, 2015
News Daily News La Aprobación de la FDA de Cangrelor Amplía las Opciones Antiplaquetarias para la PCI Todd Neale June 29, 2015
News Daily News FDA Approval of Cangrelor Expands Antiplatelet Options for PCI Todd Neale June 29, 2015
News Daily News BRAVE 4: Prasugrel Plus Bivalirudin Fails to Mitigate Stent Thrombosis in STEMI Patients May 14, 2014
News Conference News ACC 2014 CHAMPION PHOENIX Analysis: Cangrelor Reduces Early Stent Thrombosis, Suggesting Mortality Benefit April 02, 2014
Presentation ACC 2014 Incidence and Impact of Stent Thrombosis During Percutaneous Coronary Intervention: Comparison of Cangrelor and Clopidogrel from the CHAMPION PHOENIX Trial Presenter: Philippe Généreux March 30, 2014
News Daily News Un Panel de la FDA Rechaza el Cangrelor para las Indicaciones PCI y Terapia Puente Yael L. Maxwell February 13, 2014
News Daily News FDA Panel Rejects Cangrelor for Both PCI, Bridging Indications Yael L. Maxwell February 13, 2014